Test Price
2,800 AED✅ Home Collection Available
DYSF Gene Limb‑Girdle Muscular Dystrophy Type 2B (LGMD2B/R2) Genetic Test in UAE 2,800 AED | DHA‑Accredited Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑certified NGS with Sanger confirmation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation by a DHA‑licensed genetic counsellor.
- Insurance Support: Direct Billing Verification – send your policy via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Next‑Generation Sequencing of the entire DYSF gene detects all pathogenic variants causing autosomal recessive limb‑girdle muscular dystrophy type 2B (LGMD2B/R2, dysferlinopathy). This test is the definitive genetic diagnosis for patients with progressive proximal muscle weakness, elevated CK, and a compatible family history. Full gene analysis includes exons and intron‑exon boundaries, plus detection of copy number variants.
Comparison: Our NGS Panel vs. Conventional Sanger Sequencing
| Feature | DHA‑Accredited DYSF NGS | Single‑Gene Sanger Sequencing |
|---|---|---|
| Target Coverage | Full DYSF gene (exons + intron‑exon boundaries) ± CNV detection | Selected exons only; may miss deep intronic or large deletions |
| Analytical Sensitivity | >99.9% for SNVs/indels; NGS + Sanger confirmation | ~98% for point mutations; no CNV detection |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Clinical Report | DHA‑compliant integrative report with ACMG variant classification | Basic mutation listing without comprehensive interpretation |
Physician Insight & Safety Protocols
“A precise genetic diagnosis empowers patients and families with clarity for prognosis and family planning. However, this test must be interpreted alongside a comprehensive neurological evaluation. It does not replace ongoing clinical monitoring or prescribed therapies. I always counsel patients that genetic results are one piece of a larger clinical picture.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication (e.g., corticosteroids, cardiac drugs) without consulting your treating physician. Abrupt cessation may worsen muscle function or trigger a medical emergency.
Safety Exclusion Criteria & Urgent Red Flags
- This test is not suitable for emergency diagnosis of acute rhabdomyolysis or rapidly progressive respiratory failure.
- Minors require written consent from both parents/legal guardians in compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Seek immediate emergency care (call 998) if you experience sudden difficulty breathing, severe chest pain, or loss of consciousness.
- Do not self‑refer without prior genetic counselling; a pre‑test consultation is mandatory.
Patient FAQ & Clinical Guidance
1. What is the DYSF gene test, and how does it help my diagnosis?
The DYSF gene test identifies pathogenic variants causing Limb‑Girdle Muscular Dystrophy Type 2B, confirming the diagnosis and guiding targeted management. We sequence the entire DYSF gene using Next‑Generation Sequencing, followed by Sanger validation of all clinically relevant mutations. Results enable accurate genetic counselling, prognosis assessment, and family screening.
2. How should I prepare for the blood collection, and is home service available in the UAE?
Preparation is minimal: no fasting required, maintain normal hydration, and provide a detailed clinical history. Our DHA‑licensed phlebotomists arrive at your home with temperature‑controlled transport kits, ensuring sample integrity. The paid VIP mobile service operates daily from 8 AM to 11 PM across all Emirates, including Abu Dhabi, Dubai, and Sharjah.
3. Will my genetic data remain confidential under UAE law?
Absolutely. All genetic information is protected by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genomic data is stored on encrypted servers within the UAE, used solely for the requested analysis, and never shared without explicit consent. We follow strict ISO 9001:2015 quality and data governance standards (Cert: INT/EGQ/2509DA/3139).
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies fully with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019. All genetic and personal data is processed in accordance with the highest standards of confidentiality and security. The laboratory is ISO 9001:2015 certified, and all clinical activities adhere to the UAE Ministry of Health and Prevention guidelines as well as the Dubai Health Authority regulations.
Clinical & Logistical Metadata
| Test Name | DYSF Gene Limb‑Girdle Muscular Dystrophy Type 2B (LGMD2B/R2) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmation |
| ICD‑10‑CM Code | G71.0 |
| LOINC Code | 82204-3 |
| DHA Facility License & Lab Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians